Technical Analysis for IQV - IQVIA Holdings, Inc.

Grade Last Price % Change Price Change
C 228.09 0.40% 0.92
IQV closed up 0.4 percent on Friday, April 19, 2024, on 83 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 2
*** please verify all earnings dates ***
5 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish 0.40%
Lower Bollinger Band Walk Weakness 0.40%
Down 3 Days in a Row Weakness 0.40%
Down 4 Days in a Row Weakness 0.40%
Down 5 Days in a Row Weakness 0.40%
Gapped Down Weakness 0.40%
Lower Bollinger Band Touch Weakness 0.40%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 20 hours ago
Possible Inside Day about 20 hours ago
60 Minute Opening Range Breakdown about 22 hours ago
Up 1% about 24 hours ago
Up 1% 2 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

IQVIA Holdings, Inc. Description

IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Life Sciences Technology Solutions Project Management Healthcare Service Biopharmaceutical Development Q2 Technology Enabled Healthcare Services

Is IQV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 261.73
52 Week Low 167.42
Average Volume 936,577
200-Day Moving Average 219.86
50-Day Moving Average 243.68
20-Day Moving Average 240.66
10-Day Moving Average 234.13
Average True Range 5.39
RSI (14) 31.51
ADX 28.33
+DI 10.94
-DI 32.40
Chandelier Exit (Long, 3 ATRs) 240.12
Chandelier Exit (Short, 3 ATRs) 238.88
Upper Bollinger Bands 257.77
Lower Bollinger Band 223.55
Percent B (%b) 0.13
BandWidth 14.22
MACD Line -4.96
MACD Signal Line -2.93
MACD Histogram -2.0281
Fundamentals Value
Market Cap 41.63 Billion
Num Shares 183 Million
EPS 5.96
Price-to-Earnings (P/E) Ratio 38.27
Price-to-Sales 2.68
Price-to-Book 6.86
PEG Ratio 1.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 234.55
Resistance 3 (R3) 234.42 232.13 233.47
Resistance 2 (R2) 232.13 230.49 232.20 233.11
Resistance 1 (R1) 230.11 229.47 231.12 230.24 232.75
Pivot Point 227.83 227.83 228.33 227.89 227.83
Support 1 (S1) 225.80 226.18 226.82 225.94 223.43
Support 2 (S2) 223.52 225.16 223.59 223.07
Support 3 (S3) 221.50 223.52 222.71
Support 4 (S4) 221.63